Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$27,000.00
Chronic cannabinoid-mediated modulation of renal function in chronic kidney disease (CKD)
EF 2024-25
Résumé
Chronic Kidney Disease (CKD) develops when the kidneys become damaged over time and can no longer perform tasks like getting rid of waste products from the body. This in turn increases the chances of other health problems like cardiovascular disease and of having a stroke or heart attack. Other symptoms that come with CKD may not be as serious, but can be very unpleasant such as pain, itching, skin rashes and nausea, and are often left untreated.Following legalization of cannabis in Canada, one of its active components, cannabidiol (CBD), has been suggested as a potential treatment option for management of CKD- associated symptoms like pain and skin rashes. But the effects of taking CBD for prolonged periods on the kidneys havent been studied in the setting of CKD. This is important as CBD may affect how kidney work. This may be ok in people with healthy kidneys but could be bad for people with CKD. There is also a possibility that CBD could be beneficial and reduce some of the serious consequences of CKD such as cardiovascular disease; we just dont know until we take a look! We cannot do this type of study in humans and so the overall goal of this project is to find out what effect taking CBD for a prolonged period has in an animal model of CKD, which is very similar to the human disease. We will give CBD to both rats that have CKD and healthy rats for 6-8 weeks and then measure how their kidneys and blood vessels are working compared to animals not given CBD. It is anticipated that the results from this project will generate new information on the benefits and/or drawbacks of CBD use in CKD. This may have significant impact given the availability of over the counter CBD products which may be accessed by CKD patients without medical supervision.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530005
Name
McInroy Caleb P
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Chronic cannabinoid-mediated modulation of renal function in chronic kidney disease (CKD)
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cannabidiol; Chronic Kidney Disease; Renal Physiology; Renal Sympathetic Nerve Activity; Subtotal Nephrectomy; Vascular Function And Autoregulation
Abstract
Chronic Kidney Disease (CKD) develops when the kidneys become damaged over time and can no longer perform tasks like getting rid of waste products from the body. This in turn increases the chances of other health problems like cardiovascular disease and of having a stroke or heart attack. Other symptoms that come with CKD may not be as serious, but can be very unpleasant such as pain, itching, skin rashes and nausea, and are often left untreated.Following legalization of cannabis in Canada, one of its active components, cannabidiol (CBD), has been suggested as a potential treatment option for management of CKD- associated symptoms like pain and skin rashes. But the effects of taking CBD for prolonged periods on the kidneys havent been studied in the setting of CKD. This is important as CBD may affect how kidney work. This may be ok in people with healthy kidneys but could be bad for people with CKD. There is also a possibility that CBD could be beneficial and reduce some of the serious consequences of CKD such as cardiovascular disease; we just dont know until we take a look! We cannot do this type of study in humans and so the overall goal of this project is to find out what effect taking CBD for a prolonged period has in an animal model of CKD, which is very similar to the human disease. We will give CBD to both rats that have CKD and healthy rats for 6-8 weeks and then measure how their kidneys and blood vessels are working compared to animals not given CBD. It is anticipated that the results from this project will generate new information on the benefits and/or drawbacks of CBD use in CKD. This may have significant impact given the availability of over the counter CBD products which may be accessed by CKD patients without medical supervision.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
McInroy, Caleb P
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~